The GLP is committed to full transparency. Download and review our 2019 Annual Report

synbio

Using engineered gut bacteria to fight genetic disease

A Boston-based synthetic biology company is taking a novel approach to treating the rare genetic metabolic disorder Phenylketonuria. Synlogic uses ...